AKT1 and breast carcinoma: NQO1 could bind to liver-type pyruvate kinase (PKLR), which activates the AMP-activated protein kinase (AMPK) and AKT/mTOR signaling pathway, and ultimately induce glycolytic reprogramming and EMT in breast cancer.